Today, Israeli company EarlySense announced that Sheba Medical Center in Israel has implemented its contact-free continuous monitoring (CFCM) to remotely monitor isolated COVID-19 patients while limiting exposure of health staff.
EarlySense says it is now prepared to offer its solution to additional hospitals and skilled nursing facilities to assist in the global battle against coronavirus.
EarlySense’s contact-free continuous monitoring (CFCM) system tracks respiratory rate, heart rate and movement without ever touching the patient. The sensor, placed under the patient’s mattress, transmits real-time patient data for the early detection of clinical changes to a display outside of the patient’s room, limiting the need for staff to gown up and enter isolation areas. As a contact-free monitoring solution, there are no leads or other wearable devices to adjust or to touch the patient’s body.
Dr. Eyal Zimlichman, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center, said: “We are grateful to EarlySense for answering an open call from our ARC innovation center for technologies and providing its contact-free patient monitoring system. Together with additional protocols, we are well-prepared to care for our isolated COVID-19 patients”.
Matt Johnson, EarlySense CEO, said: “As the coronavirus continues to spread across the globe, health facilities are challenged to effectively care for patients while also keeping staff safe from exposure”.
Sheba Medical Center, in Ramat Gan, near Tel Aviv, is the largest medical centre in the Middle East, and is ranked by Newsweek as one of the 2020 top 10 hospitals in the world.
